Intravenous Solution Market Expected to Reach USD 11,511.2 Million Till 2022 by MRFR

Pune, India -- (SBWire) -- 09/18/2018 --Intravenous Solution (IV) Market – Synopsis

The Market For Intravenous (IV) Solution Is Expected To Reach USD 11,511.2 Million By 2022 And Is Expected To Grow At A CAGR Of 7.69% During The Forecast Period 2016-2022. Intravenous (IV) Solution are intended to be administered to the patients which are deficient in nutrients or at the time of serious dehydration.

Request for Sample Report at https://www.marketresearchfuture.com/sample_request/1235

These solutions are given to the patients whose fluid volume or body nutrients falls. Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for intravenous solutions is growing swiftly.

The factors which drive the growth of the market are the rising prevalence of chronic diseases, rising acceptance of vitamin C intravenous treatment therapy to treat colorectal cancer. 

Top Players:

ICU Medical,

B. Braun Melsungen

Fresenius Kabi

Baxter

Amanta Healthcare

And others.

Intravenous Solution Market - Segmentation:

Global IV Solutions Market has been segmented on the basis of types which comprises of Peripheral Parenteral Nutrition and Total Parenteral Nutrition.

On the basis of nutritional content which comprises of Amino acid solution, Carbohydrates, Vitamins & minerals, parenteral lipid emulsion and others.

On the basis of end users the global IV solutions market includes Hospital & Clinics, Ambulatory and Home Care.

Ask Any Question at https://www.marketresearchfuture.com/enquiry/1235

Intravenous Solution Market - Regional Analysis:

The global market for IV Solutions is growing steadily. The market for IV Solutions is growing with the CAGR of 7.69% during the forecast period from 2016-2022. North America accounts for largest market share in 2015 and is expected to reach USD 6,543.4 million by 2022.

This is attributed to the factors such as Growing acceptance of vitamin C intravenous for Colorectal Cancer and increasing prevalence of the chronic diseases. Europe is the second largest market which is growing at a CAGR of 8.12% from 2016-2022. Asia-Pacific region is the fastest growing market for IV Solutions, which is expected to grow at a CAGR of 8.34% during the forecast period from 2016 to 2022.

Key Finding:

The Global Intravenous (IV) Solution Market and is expected to reach USD 11,511.2 million by 2022
By type, Total Parenteral Nutrition (TPN) holds the largest market share of global Intravenous (IV) Solution market and is expected to reach USD 4,940.0 million in 2016
By nutritional content, amino acid solution holds the largest market share of global Intravenous (IV) Solution market is expected to reach USD 2,385.0 million in 2016
Major TOC of Intravenous (IV) Solution Market Research Report- Global Forecast to 2022:

1 REPORT PROLOGUE

2 INTRODUCTION

3 RESEARCH METHODOLOGY

4 MARKET DYNAMICS

5 MARKET FACTOR ANALYSIS

6 GLOBAL IV SOLUTION MARKET, BY TYPES

7 GLOBAL IV SOLUTION MARKET, BY NUTRITIONAL CONTENT

8 GLOBAL IV SOLUTION MARKET, BY END USERS

9 GLOBAL IV SOLUTION MARKET, BY REGIONS

10 COMPANY SHARE ANALYSIS

11 COMPANY PROFILES

12 MRFR CONCLUSION

13 APPENDIX

14 List of Tables

15 List of Figure

Check Discount Here at https://www.marketresearchfuture.com/check-discount/1235

About Market Research Future
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com